Joint Biosciences (SH), Ltd. (referred to as "JBS"), Located in The Industrial Park of Cell Therapy in Shanghai International Medical Park, China. It is a modern integrated platform facility for research and development of molecular biology, virus and cell therapy drugs，focusing on combination immunotherapy to develop First-in-Class medicines for solid tumors.
The founder and management team of the company is a high-level international team, composed of a group of technical experts in US and China’s major biotech and pharma companies for more than 20 years, with rich experience in the fields of virology, immunology, tumor and translational medicine, virus and cell therapy drug R &D, published many high-cited research papers such as Nature, Science, Cell, etc. They are the Pioneers of development of combination therapeutic drugs for solid tumors.
Joint Biosciences' Oncolytic Virus Therapy OVV-01 Receives U.S...
FDA clearance of Intravenous (IV) and intravenous + intratumoral (...
First-in-Class Oncolytic Virus OVV-01 Presented in Oral Sessio...
WeChat Official Account
Copyright?2020 上海榮瑞醫(yī)藥科技有限公司 保留所有權(quán)利 滬ICP備88888888號Technical support：Zhulu
